Title: MP-06.05: Fesoterodine versus tolterodine for overactive bladder in older and younger subjects
Abstract: We compared the efficacy and safety of fesoterodine (FESO) 8 mg vs tolterodine extended release (TER) 4 mg for the treatment of overactive bladder (OAB) symptoms in subjects aged <65 y and ≥65 y.
Publication Year: 2010
Publication Date: 2010-09-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot